Aquatic Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Aquatic Capital Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.61M	Buy	69,083 +67,040	+3,281%	+$1.46M	0.05%	439
2025 Q4	$42.9K	Buy	+2,043	New	+$35.6K	﹤0.01%	1268
2024 Q4	–	Sell	-6,200	Closed	-$119K	–	1589
2024 Q3	$119K	Buy	+6,200	New	+$128K	﹤0.01%	902
2022 Q1	–	Sell	-500	Closed	-$11K	–	1490
2021 Q4	$11K	Buy	+500	New	+$9.24K	0.02%	776

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Aquatic Capital Management's SNDX Position: Q1 2026 in Review

Aquatic Capital Management increased its Syndax Pharmaceuticals (SNDX) stake by 3,281% in Q1 2026, buying an estimated $1.46M and bringing the position to 69,083 shares worth $1.61M. The position accounts for 0.05% of the portfolio, ranked #439.

Aquatic Capital Management first reported a position in SNDX in Q4 2021 and has held it in 4 quarters since. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

Aquatic Capital Management held 69,083 shares of Syndax Pharmaceuticals worth $1.61M as of Q1 2026.
Aquatic Capital Management bought 67,040 Syndax Pharmaceuticals shares in Q1 2026, an estimated $1.46M.
Syndax Pharmaceuticals made up 0.05% of Aquatic Capital Management's portfolio in Q1 2026, its #439 holding.
Aquatic Capital Management first reported a position in Syndax Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.